United Advisor Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $202K | Buy |
385
+4
| +1% | +$2.1K | 0.03% | 377 |
|
|
2025
Q1 | $242K | Sell |
381
-74
| -16% | -$46.9K | 0.05% | 308 |
|
|
2024
Q4 | $324K | Sell |
455
-94
| -17% | -$67K | 0.06% | 283 |
|
|
2024
Q3 | $577K | Buy |
549
+224
| +69% | +$235K | 0.13% | 161 |
|
|
2024
Q2 | $342K | Buy |
325
+30
| +10% | +$31.5K | 0.11% | 185 |
|
|
2024
Q1 | $284K | Buy |
+295
| New | +$284K | 0.11% | 168 |
|